Overview
Slow channel syndrome, often associated with calcium channel blocker (CCB) overdose, particularly lercanidipine and amlodipine, presents with severe hemodynamic instability and multi-organ dysfunction, necessitating aggressive management strategies 1.Diagnosis
Clinical presentation includes shock, bradycardia, hypotension, and signs of multi-organ failure 1.
Laboratory tests may reveal electrolyte imbalances, particularly hypokalemia, and elevated cardiac biomarkers 1.
Specific diagnostic criteria often rely on history of CCB ingestion and exclusion of other causes of shock 1.Management
First-line treatments: Fluid resuscitation, calcium gluconate, and glucagon to stabilize hemodynamics 1.
Adjunctive therapies: High-dose insulin-euglycemia therapy to manage refractory shock 1.
Advanced interventions: Charcoal hemoperfusion combined with continuous venovenous hemodiafiltration for severe cases refractory to conventional therapies 1.Special Populations
No specific data provided for pregnancy, pediatrics, elderly, or comorbidities in the given abstracts 1.Key Recommendations
Initiate fluid resuscitation and administer calcium gluconate early in the management of CCB overdose (Evidence: Strong 1).
Consider high-dose insulin-euglycemia therapy for patients with refractory shock (Evidence: Moderate 1).
Employ charcoal hemoperfusion and continuous venovenous hemodiafiltration for severe cases unresponsive to initial treatments (Evidence: Weak 1).References
1 Nasa P, Singh A, Juneja D, Singh O, Javeri Y. Continuous venovenous hemodiafiltration along with charcoal hemoperfusion for the management of life-threatening lercanidipine and amlodipine overdose. Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia 2014. link